ATE284216T1 - Formulierungen und verfahren zur verminderung von hautirritationen - Google Patents

Formulierungen und verfahren zur verminderung von hautirritationen

Info

Publication number
ATE284216T1
ATE284216T1 AT95944552T AT95944552T ATE284216T1 AT E284216 T1 ATE284216 T1 AT E284216T1 AT 95944552 T AT95944552 T AT 95944552T AT 95944552 T AT95944552 T AT 95944552T AT E284216 T1 ATE284216 T1 AT E284216T1
Authority
AT
Austria
Prior art keywords
methods
formulations
reducing skin
skin irritations
skin irritation
Prior art date
Application number
AT95944552T
Other languages
English (en)
Inventor
Gary Scott Hahn
David Orel Thueson
Original Assignee
Cosmederm Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23424700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284216(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cosmederm Technologies filed Critical Cosmederm Technologies
Application granted granted Critical
Publication of ATE284216T1 publication Critical patent/ATE284216T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95944552T 1994-12-21 1995-12-21 Formulierungen und verfahren zur verminderung von hautirritationen ATE284216T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36210194A 1994-12-21 1994-12-21
PCT/US1995/016990 WO1996019228A1 (en) 1994-12-21 1995-12-21 Formulations and methods for reducing skin irritation

Publications (1)

Publication Number Publication Date
ATE284216T1 true ATE284216T1 (de) 2004-12-15

Family

ID=23424700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944552T ATE284216T1 (de) 1994-12-21 1995-12-21 Formulierungen und verfahren zur verminderung von hautirritationen

Country Status (9)

Country Link
EP (1) EP0801570B1 (de)
JP (1) JPH10511360A (de)
AT (1) ATE284216T1 (de)
AU (1) AU4690196A (de)
BR (1) BR9510488A (de)
CA (1) CA2208268A1 (de)
DE (1) DE69533842T2 (de)
MX (1) MX9704775A (de)
WO (1) WO1996019228A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2719474B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
EP0737471A3 (de) * 1995-04-10 2000-12-06 L'oreal Verwendung von Erdalkalimetallsalze als TNF-alpha Inhibitor in einer topischen Zusammensetzung und die so hergestellte Zusammensetzung
DE69601765T2 (de) 1995-09-07 1999-07-08 Oreal Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
US6168798B1 (en) * 1997-02-03 2001-01-02 Bristol-Myers Squibb Company Non-irritating composition for treating acne and other skin conditions
FR2762839B1 (fr) * 1997-04-30 2001-05-11 Oreal Nouveaux derives de l'acide salicylique et leur utilisation dans une composition cosmetique et/ou dermatologique
US6281400B1 (en) 1997-07-29 2001-08-28 E. I. Du Pont De Nemours And Company Process for preparation of a catalytic microcomposite from a silicate and a highly fluorinated ion exchange resin
US5972321A (en) * 1998-06-30 1999-10-26 Akpharma Inc. Acid neutralization of skin
US6042816A (en) * 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US5955065A (en) * 1998-08-19 1999-09-21 The Gillette Company Antiperspirant compositions containing calcium salts
FR2791260B1 (fr) * 1999-03-26 2003-06-06 Dior Christian Parfums Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l'expression des recepteurs membranaires cd44 des cellules de la peau
US6447754B1 (en) 2000-01-24 2002-09-10 Akpharma Inc. Oral rinse methods and compositions
US7851477B2 (en) 2003-05-22 2010-12-14 L'oreal Method for the treatment of skin
ITMI20040665A1 (it) * 2004-04-02 2004-07-02 Pharmaproducts Uk Ltd Sale di calcio per il trattamento della psoriasi e di dermatiti
US7704531B2 (en) 2005-02-18 2010-04-27 Colgate-Palmolive Company Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
FR2918883B1 (fr) 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
WO2010078419A2 (en) * 2008-12-31 2010-07-08 Bzmi, Llc Herbal-based nasal solution and method of use thereof
WO2011010075A1 (fr) 2009-07-24 2011-01-27 L'oreal Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2968952A1 (fr) 2010-12-17 2012-06-22 Oreal Ester d'acide amine n-acyle a titre d'agent apaisant
US20160228339A1 (en) * 2013-09-18 2016-08-11 Glymur B.V. Oral hygiene compositions
JP6599854B2 (ja) * 2013-10-09 2019-10-30 リーマン トレーディング アンパーツゼルスカブ 改善された制汗剤組成物
EP3174409A4 (de) 2014-07-31 2018-01-17 Amorphical Ltd. Eingekapselte amorphe calciumcarbonatzusammensetzungen
DE102018206624A1 (de) * 2018-04-27 2019-10-31 Beiersdorf Ag Antitranspirantwirksame Zubereitung umfassend Erdalkalimetallsalze und Carbonsäuren

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1072355A (en) * 1964-06-17 1967-06-14 Michael Collin Antiseptic and anti-pruretic solution containing camphor
US3865546A (en) * 1970-10-22 1975-02-11 Collaborative Res Inc Depilatory composition and method of use
GB1334933A (en) * 1971-02-19 1973-10-24 Ahrens G W Reaction products of caldium ascorbate and preparation containing them
US3984540A (en) * 1972-12-20 1976-10-05 Caw Industries, Inc. Method of therapeutically treating damaged and/or infected tissue in warm blooded animals and compositions therefor
US4083965A (en) * 1975-01-16 1978-04-11 Bluhm Henry P Method of and composition for relieving itch, pain and swelling resulting from insect stings and bites and skin contact with noxious plants
US4248861A (en) * 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
US4477439A (en) * 1981-04-13 1984-10-16 Walter J. Monacelli Treatment of irritated and excoriated areas around the stoma of ostomy patients
EP0137743A3 (de) * 1983-09-13 1986-10-01 Ed. Geistlich Söhne Ag Für Chemische Industrie Topisch anwendbare Arzneimittel
DE3435113A1 (de) * 1984-05-07 1986-04-03 Gödecke AG, 7800 Freiburg Pharmazeutische topische zubereitungen zur foerderung der wundgranulation und epithelisation
JPS61109725A (ja) * 1984-11-02 1986-05-28 Kamehiko Mogi 軟膏
ATE69954T1 (de) * 1985-10-08 1991-12-15 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
JP2527174B2 (ja) * 1987-03-02 1996-08-21 三菱化学株式会社 皮膚用製剤
US4917889A (en) * 1988-07-14 1990-04-17 Thomas W. Clarke Topical composition and treatment
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
JP2681527B2 (ja) * 1990-02-15 1997-11-26 ジャパンファインケミカル株式会社 細胞活性促進外用剤
JPH045224A (ja) * 1990-04-20 1992-01-09 Kao Corp 皮膚清浄・清拭剤組成物
US5571535A (en) * 1990-11-30 1996-11-05 Flowers; Marianne Treatment of topical infections
JPH0735326B2 (ja) * 1990-12-28 1995-04-19 仁尾興産株式会社 入浴剤
JPH05117158A (ja) * 1991-10-22 1993-05-14 Sasaki Kagaku Yakuhin Kk 皮膚外用剤組成物
JPH05123398A (ja) * 1991-11-06 1993-05-21 Tsunemasa Kamiyama 咽喉保護吸入剤並びに吸入器具
JPH0742211B2 (ja) * 1992-01-31 1995-05-10 忠 鄭 水性皮膚及び頭皮・頭髪化粧料
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
JPH06135840A (ja) * 1992-10-22 1994-05-17 Asahi Optical Co Ltd 口内及び外皮・外傷の洗浄消毒剤
WO1994009798A1 (en) * 1992-10-29 1994-05-11 C-P Technology Limited Partnership Mixtures or complexes containing calcium and sulfate

Also Published As

Publication number Publication date
EP0801570B1 (de) 2004-12-08
JPH10511360A (ja) 1998-11-04
BR9510488A (pt) 1998-01-13
DE69533842D1 (de) 2005-01-13
EP0801570A4 (de) 1998-12-30
MX9704775A (es) 1998-02-28
EP0801570A1 (de) 1997-10-22
CA2208268A1 (en) 1996-06-27
DE69533842T2 (de) 2006-02-16
AU4690196A (en) 1996-07-10
WO1996019228A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
ATE284216T1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
DE69530418D1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
ATE283032T1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
DE69527765D1 (de) Verwendung von Hyaluronsäure oder sein Salz zur Behandlung von Hauterkrankungen
BR9609503A (pt) Composto, uso de um composto, processo de tratamento de condições onde a inibição de pde especìfico para cgmp é de benefìcio terapêutico, em corpo de animal humano ou não humano, composição farmacêutica, e processos para preparar a mesma e um composto
BR0116832A (pt) Produto desodorante, método cosmético e método de fabricação de composição desodorante
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
ATE89159T1 (de) Topische zusammensetzung und verfahren zur anregung des haarwuchses.
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATE235226T1 (de) Arzneimittel insbesondere zur vorbeugung und behandlung von strahlungs- und chemomukositiden
DE69501105D1 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE69308969D1 (de) Titansalz enthaltende, schweisshemmende Mittel und Zusammensetzung
DE69512589D1 (de) Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
NZ334593A (en) Use of zinc salts of conjugated linoleic acids to treat skin disorders particularly eczema, psoriasis and dermatitis and their use in the treatment of skin cancer
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
EP0801945A3 (de) Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
DE68921209D1 (de) Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
ATE85219T1 (de) Dermatologische und kosmetische zusammensetzungen auf der basis von alkoylcarboxamid und zink- salzen zur behandlung von seborrhoid-dermatitis und/oder von seborrhoid-stoerungen.
ATE157530T1 (de) Mittel zur dauerhaften haarverformung
TR200200267T2 (tr) Atıkları muamele etmek için karışım.
JO1499B1 (en) New Derivatives of 16,17-Acetal Acid Replaced by Brennan 21-Uic
DE69630684D1 (de) Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
JPS5587713A (en) Weakly acidic nursery powder

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties